European Journal of Medicinal Chemistry Reports : Impact Factor & More
eISSN: 2772-4174
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
European Journal of Medicinal Chemistry Reports Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 1500 |
| Publication Time | 16 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in European Journal of Medicinal Chemistry Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Journal of Medicinal Chemistry Reports
1,4-dihydropyridine–hydrazone hybrids as novel scaffold for serine protease inhibitors: Synthesis, in vitro and in silico drug-likeness studies
- 1 Aug 2026
- European Journal of Medicinal Chemistry Reports
Peptide-mediated modulation of miRNAs: A novel therapeutic strategy for cancer
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
2-Morpholino-substituted imidazothiadiazole TAK1 inhibitors for reduction of proinflammatory cytokines
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
Sanguinarine alleviates cisplatin-induced apoptosis in AKI by upregulating BCL-2 through targeting the gene promoter i-motif
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
Mechanisms of Panax notoginseng in the treatment of vascular disease: A review and preliminary analysis
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
Fragment-based discovery of novel small molecule targeting human BAG3
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
1,4-dihydropyridine–hydrazone hybrids as novel scaffold for serine protease inhibitors: Synthesis, in vitro and in silico drug-likeness studies
- 1 Aug 2026
- European Journal of Medicinal Chemistry Reports
Peptide-mediated modulation of miRNAs: A novel therapeutic strategy for cancer
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
2-Morpholino-substituted imidazothiadiazole TAK1 inhibitors for reduction of proinflammatory cytokines
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
Sanguinarine alleviates cisplatin-induced apoptosis in AKI by upregulating BCL-2 through targeting the gene promoter i-motif
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
Mechanisms of Panax notoginseng in the treatment of vascular disease: A review and preliminary analysis
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
Fragment-based discovery of novel small molecule targeting human BAG3
- 1 Apr 2026
- European Journal of Medicinal Chemistry Reports
FAQs on European Journal of Medicinal Chemistry Reports
How many articles did European Journal of Medicinal Chemistry Reports publish last year? 
Who is the publisher of European Journal of Medicinal Chemistry Reports?
